Efficacy of trimetazidine for myocardial ischemia-reperfusion injury in rat models: a systematic review and meta-analysis

Efficacy of trimetazidine for myocardial ischemia-reperfusion injury in rat models: a systematic review and meta-analysis

Context Trimetazidine (TMZ) is used as a medication for ischemic heart disease treatment. Recently, several animal models have been studied in relation to the research on myocardial ischemia-reperfusion injury (MIRI) treatment. In this study, we conducted a meta-analysis of TMZ in rat MIRI models to...

Full description

Saved in:

Bibliographic Details
Main Authors:	Xiaobin Zhang, Zhanhui Duan, Yanpu Yu, Chunjing Li, Mingyao Hao, Yuning Ma, Yuxia Ma, Dongqing Du
Format:	Article
Language:	English
Published:	PeerJ Inc. 2025-06-01
Series:	PeerJ
Subjects:	Myocardial ischemia-reperfusion injury Trimetazidine Superoxide dismutase Creatine kinase isoenzyme Myocardial infarct size Systematic review
Online Access:	https://peerj.com/articles/19515.pdf
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Antioxidant activity of rat liver with a low resistance to hypoxia after systemic ischemia reperfusion
by: Gulnar A. Bayburina, et al.
Published: (2021-12-01)

The influence of trimetazidine hydrochloride on acute ischemia-reperfusion injury of endothelial cells and oxidative stress response of rat kidney
by: DU Yi, et al.
Published: (2017-01-01)

Effects of trimetazidine on oxidant-antioxidant balance and angiogenesis; an in vivo experimental study
by: Fethullah Kayan, et al.
Published: (2025-04-01)

Novel Aspects of Cardiac Ischemia and Reperfusion Injury Mechanisms
by: T. A. Yagudin, et al.
Published: (2019-01-01)

Trimetazidine effects on red blood cell membrane lipids and necrosis area size in thrombolytic therapy of myocardial infarction
by: T. Yu. Rebrova, et al.
Published: (2009-04-01)

IL‐38 attenuates myocardial ischemia–reperfusion injury by inhibiting macrophage inflammation
by: Yuzhen Wei, et al.
Published: (2023-06-01)

Downregulation of Gldc attenuates myocardial ischemia reperfusion injury in vitro by modulating Akt and NF-κB signalings
by: Lian Shuang, et al.
Published: (2025-01-01)

Protective effect of exercise induced metabolite-3 in ischemia-reperfusion injury
by: Zijie CHENG, et al.
Published: (2025-06-01)

Immune in myocardial ischemia/reperfusion injury: potential mechanisms and therapeutic strategies
by: Xiaoyu Xuan, et al.
Published: (2025-05-01)

Clinical manifestations and basic mechanisms of myocardial ischemia/reperfusion injury
by: Chiu-Fen Yang
Published: (2018-01-01)

Cardiac MRI of differing ischemia and reperfusion times in a myocardial infarction pig model
by: David Boll, et al.
Published: (2025-07-01)

The Role of Cardiac Macrophages in Inflammation and Fibrosis after Myocardial Ischemia-Reperfusion
by: Kaiqin Jin, et al.
Published: (2024-11-01)

Comparison of the proteomic landscape in experimental ischemia reperfusion with versus without ischemic preconditioning
by: Yalda Kakaei, et al.
Published: (2025-04-01)

Pharmacological treatment of stable angina pectoris: the place of trimetazidine
by: E. A. Temnikova
Published: (2022-12-01)

The interaction between ferroptosis and myocardial ischemia–reperfusion injury: molecular mechanisms and potential therapeutic targets
by: Tiantian Zhang, et al.
Published: (2025-07-01)

Macrophage Polarization in Myocardial Ischemia&#x2012;Reperfusion Injury: Pathophysiology and Therapeutic Targets
by: Liu G, et al.
Published: (2025-07-01)

TRIMETAZIDINE MR EFFECTS ON THE PARAMETERS OF 24-HOUR ELECTROCARDIOGRAM MONITORING AND HEART RATE VARIABILITY
by: M. V. Novikova, et al.
Published: (2013-10-01)

Role of biomarkers of myocardial injury and inflammation in predicting ischemia-reperfusion injury in patients with ST-segment elevation acute coronary syndrome undergoing endovascular revascularization
by: T. V. Rusak, et al.
Published: (2021-12-01)

Significance of determination of biomarkers of myocardial necrosis in acute coronary syndrome
by: Matunović Radomir, et al.
Published: (2005-01-01)

Protective Effect of Exercise Preconditioning on Myocardial Ischemia-Reperfusion Injury in Rats Based on Autophagy
by: Qiang TANG, et al.
Published: (2019-10-01)

Gastrodin reduces myocardial ischemia/reperfusion injury via transgelin2/CNPase-mediated apoptosis regulation
by: Changyan Li, et al.
Published: (2025-07-01)

Quercetin improves myocardial ischemia–reperfusion injury by regulating macrophage M2 polarization through Bcl-2/Beclin-1 complex
by: Sailing Hu, et al.
Published: (2025-08-01)

Integrating Network Pharmacology and in vivo Validation to Explore the Mechanisms of Buyang Huanwu Decoction in Myocardial Ischemia-Reperfusion Injury
by: Luo Y, et al.
Published: (2025-06-01)

Dexmedetomidine Ameliorates Myocardial Ischemia‐Reperfusion Injury by Inhibiting MDH2 Lactylation via Regulating Metabolic Reprogramming
by: Han She, et al.
Published: (2024-12-01)

Ischemic Area‐Targeting and Self‐Monitoring Nanoprobes Ameliorate Myocardial Ischemia/Reperfusion Injury by Scavenging ROS and Counteracting Cardiac Inflammation
by: Xiaobin Ma, et al.
Published: (2025-03-01)

Evaluating the role of trimetazidine in preventing myocardial injury and contrast-induced nephropathy in patients undergoing percutaneous coronary interventions
by: Anshul Jain, et al.
Published: (2025-05-01)

4‐Octyl Itaconate Alleviates Myocardial Ischemia‐Reperfusion Injury Through Promoting Angiogenesis via ERK Signaling Activation
by: Jiqin Yang, et al.
Published: (2025-03-01)

Trimetazidine: Activating AMPK Signal to Ameliorate Coronary Microcirculation Dysfunction after Myocardial Infarction
by: Xiaolong Qu, et al.
Published: (2025-01-01)

Early Cardiac Ischemia–Reperfusion Injury: Interactions of Autophagy with Galectin-3 and Oxidative Stress
by: Suhail Al-Salam, et al.
Published: (2024-10-01)

Prediction of myocardial ischemia–reperfusion injury post-PCI: role of sST2 levels in STEMI patients
by: Wenjing Che, et al.
Published: (2025-04-01)

Trimetazidine in coronary heart disease patients: mechanism of action and controlled trials’ results
by: L. V. Kremneva, et al.
Published: (2005-04-01)

CD11b Blockade Ameliorates Myocardial Ischemia/Reperfusion Injury by Reducing Neutrophil and Monocyte Infiltration
by: Peng Fu, et al.
Published: (2025-07-01)

Myocardial ischemia – reperfusion injury
by: S. V. Salo, et al.
Published: (2023-10-01)

Puerarin pretreatment provides protection against myocardial ischemia/reperfusion injury via inhibiting excessive autophagy and apoptosis by modulation of HES1
by: Yong Yuan, et al.
Published: (2025-01-01)

Dexmedetomidine alleviatesmyocardial ischemia-reperfusion injury in rat models
by: LIU Genfeng, NAN Lu, GAO Qin, CHEN Yixuan, ZHANG Jing, YU Peng, YU Shuchun
Published: (2025-03-01)

The effect of erythropoietin on creatine phosphokinase levels during ischemia reperfusion injury in rats
by: Constantinos Tsompos, et al.

LGR6 protects against myocardial ischemia-reperfusion injury via suppressing necroptosis
by: Mengmeng Zhao, et al.
Published: (2024-12-01)

Significance of Markers of Transient Myocardial Ischemia and Hemodynamic Overload in Critically Ill Neonates
by: K. V. Budarova, et al.
Published: (2022-10-01)

PREVENTION OF COMPLICATIONS CAUSED BY MYOCARDIAL ISCHEMIA-REPERFUSION IN NONCARDIAC SURGICAL PROCEDURES
by: I. A. Kozlov
Published: (2016-06-01)

Cardiotoxic and Cardioprotective Effects of Methylene Blue in the Animal Model of Cardiac Ischemia and Reperfusion
by: Hezio Jadir Fernandes Junior, et al.
Published: (2024-11-01)